Trexquant Investment LP Next Cure, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.38 - $5.27 $124,995 - $194,889	-36,981 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.76 - $6.24 $47,804 - $62,668	10,043 Added 37.28%	36,981 $180,000
Q4 2021 Feb 14, 2022	BUY	$5.7 - $9.1 $94,734 - $151,242	16,620 Added 161.08%	26,938 $162,000
Q3 2021 Nov 12, 2021	SELL	$6.74 - $8.02 $46,398 - $55,209	-6,884 Reduced 40.02%	10,318 $70,000
Q2 2021 Aug 12, 2021	BUY	$7.6 - $10.28 $130,735 - $176,836	17,202 New	17,202 $138,000
Q1 2021 May 13, 2021	SELL	$9.81 - $13.88 $150,671 - $213,182	-15,359 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$9.47 - $12.43 $145,449 - $190,912	15,359 New	15,359 $167,000
Q2 2020 Aug 07, 2020	SELL	$21.19 - $40.2 $291,087 - $552,227	-13,737 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$32.32 - $58.37 $443,979 - $801,828	13,737 New	13,737 $509,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $21.1M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.